Biotech ETFs Head to Head: XBI vs. IBB
March 01, 2018 at 17:44 PM EST
The biotech sector has been attracting a lot of investor attention lately. This sector is expected to continue benefiting from increased M&A activities, new drug approvals, better R&D and innovations.